by Bree Fowler
Watson demoed by IBM employees. Credit: Wikipedia
IBM is teaming up with the New York Genome Center to help fight brain cancer.
The company said Wednesday that its Watson cloud computing system will be used in partnership with a New York-based genetic research center mainly to help sequence DNA for the treatment of glioblastoma, the most common type of brain cancer in U.S. adults.
New York Genome Center, a consortium of academic, medical and industry officials, will use Watson to sequence the DNA of cancer tumors at much faster rate than would be possible if done by a human being. The DNA information would then be combined with clinical information and fed to Watson to help determine the best way to treat a particular patient.
What makes Watson unique is that it isn't programed like most computers. Instead of relying on the information that's put into it, Watson learns by "reading" vast amounts of information and combining it with the results of previous work to find answers to problems. Those characteristics make Watson ideal for extremely data-heavy work in fields such as health care and finance.
John Kelly, a senior vice president and director of IBM research, says there's a vast amount of data involved in DNA sequencing, which then must be combined with all of the clinical data involved in a particular patient's case. The resulting pool of information is so big that it's impossible for people to deal with.
"This is sort of big data on steroids," Kelly says.
Dr. Robert Darnell, New York Genome's president, CEO and scientific director, says that to completely analyze one person's brain tumor, doctors would have to sequence 800 billion base pairs of DNA, adding that it took him a year sequence 140 pairs by himself. In comparison, Watson can sequence 75 million base pairs in one second.
And Darnell says that once doctors know a tumor's genetic makeup, they can use Watson's computing abilities to determine the best treatment for a patient based on the tumor's mutations. For instance, if a child's leukemia shows genetic traits similar to melanoma, a melanoma drug might be successful in shrinking that child's tumor, he says.
"This is the proverbial needle in the haystack and the haystack is enormous," Kelly says. "Watson can do in seconds what would take people years. And we can get it down to a really personal level."
The doctors working on the project hope to start with 20 brain cancer patients, sequence their DNA and then run the information through Watson to figure out the best ways to treat them, Darnell says.
Armonk, New York-based IBM Corp. already has a partnership with Memorial Sloan-Kettering Cancer Center, where Watson is also used to help treat cancer. Earlier this year, IBM announced it would invest $1 billion to give Watson its own business division and headquarters in New York City.
Explore further: IBM's Watson gets its own business
© 2014 The Associated Press. All rights reserved.
Medical Xpress on facebook
Related Stories
Watson's medical expertise offered commercially
Feb 08, 2013
The Watson supercomputer is graduating from its medical residency and is being offered commercially to doctors and health insurance companies, IBM said Friday.
IBM's Watson gets its own business
Jan 09, 2014
One of the most famous "Jeopardy!" champs of all time is moving to Manhattan.
IBM, NYC hospital training Watson supercomputer in cancer
Mar 22, 2012
The medical training of IBM's speedy Watson computer will continue with a residency at a renowned Manhattan cancer hospital.
IBM sends Watson to NY college to boost its skills (Update)
Jan 30, 2013
Watson, the supercomputer famous for beating the world's best human "Jeopardy!" champions, is going to college.
IBM sees five tech-powered changes in next five years
Dec 17, 2013
Technology stalwart IBM on Tuesday predicted classrooms getting to know students and doctors using DNA to customize care are among five big changes on the horizon.
Recommended for you
Early brain development implicated in Restless Legs Syndrome
2 hours ago
In a study published online in Genome Research, researchers of the Helmholtz Zentrum München und the Technische Universität München have demonstrated that a common genetic variant associated with Restless Legs Syndrome (RLS) ...
New genetic analysis identifies ancestry, reduces false positives in pinpointing disease
Mar 18, 2014
(Medical Xpress)—Ancestral background has much to do with our likelihood of developing or staving off disease. But separating the associations between who we are and where we come from, and genetic variations ...
New research links body clocks to chronic lung diseases
Mar 17, 2014
(Medical Xpress)—The body clock's natural rhythm could be utilized to improve current therapies to delay the onset of chronic lung diseases.
Taking immune cells for a test drive
Mar 17, 2014
You're on a crowded subway car and someone nearby sneezes. Influenza viruses shed by your fellow rider are expelled in droplets of saliva that land on you and the person next to you. Two days later, you begin suffering from ...
Novel gene-finding approach yields a new gene linked to key heart attack risk factor
Mar 16, 2014
Scientists have discovered a previously unrecognized gene variation that makes humans have healthier blood lipid levels and reduced risk of heart attacks—a finding that opens the door to using this knowledge in testing ...
Cancer therapy may be too targeted
Mar 16, 2014
Researchers have identified two novel cancer genes that are associated with the development of a rare, highly aggressive, cancer of blood vessels. These genes may now act as markers for future treatments and explain why narrowly ...
User comments
© Medical Xpress 2011-2014, Science X network
by Bree Fowler
Watson demoed by IBM employees. Credit: Wikipedia
IBM is teaming up with the New York Genome Center to help fight brain cancer.
The company said Wednesday that its Watson cloud computing system will be used in partnership with a New York-based genetic research center mainly to help sequence DNA for the treatment of glioblastoma, the most common type of brain cancer in U.S. adults.
New York Genome Center, a consortium of academic, medical and industry officials, will use Watson to sequence the DNA of cancer tumors at much faster rate than would be possible if done by a human being. The DNA information would then be combined with clinical information and fed to Watson to help determine the best way to treat a particular patient.
What makes Watson unique is that it isn't programed like most computers. Instead of relying on the information that's put into it, Watson learns by "reading" vast amounts of information and combining it with the results of previous work to find answers to problems. Those characteristics make Watson ideal for extremely data-heavy work in fields such as health care and finance.
John Kelly, a senior vice president and director of IBM research, says there's a vast amount of data involved in DNA sequencing, which then must be combined with all of the clinical data involved in a particular patient's case. The resulting pool of information is so big that it's impossible for people to deal with.
"This is sort of big data on steroids," Kelly says.
Dr. Robert Darnell, New York Genome's president, CEO and scientific director, says that to completely analyze one person's brain tumor, doctors would have to sequence 800 billion base pairs of DNA, adding that it took him a year sequence 140 pairs by himself. In comparison, Watson can sequence 75 million base pairs in one second.
And Darnell says that once doctors know a tumor's genetic makeup, they can use Watson's computing abilities to determine the best treatment for a patient based on the tumor's mutations. For instance, if a child's leukemia shows genetic traits similar to melanoma, a melanoma drug might be successful in shrinking that child's tumor, he says.
"This is the proverbial needle in the haystack and the haystack is enormous," Kelly says. "Watson can do in seconds what would take people years. And we can get it down to a really personal level."
The doctors working on the project hope to start with 20 brain cancer patients, sequence their DNA and then run the information through Watson to figure out the best ways to treat them, Darnell says.
Armonk, New York-based IBM Corp. already has a partnership with Memorial Sloan-Kettering Cancer Center, where Watson is also used to help treat cancer. Earlier this year, IBM announced it would invest $1 billion to give Watson its own business division and headquarters in New York City.
Explore further: IBM's Watson gets its own business
© 2014 The Associated Press. All rights reserved.
Medical Xpress on facebook
Related Stories
Watson's medical expertise offered commercially
Feb 08, 2013
The Watson supercomputer is graduating from its medical residency and is being offered commercially to doctors and health insurance companies, IBM said Friday.
IBM's Watson gets its own business
Jan 09, 2014
One of the most famous "Jeopardy!" champs of all time is moving to Manhattan.
IBM, NYC hospital training Watson supercomputer in cancer
Mar 22, 2012
The medical training of IBM's speedy Watson computer will continue with a residency at a renowned Manhattan cancer hospital.
IBM sends Watson to NY college to boost its skills (Update)
Jan 30, 2013
Watson, the supercomputer famous for beating the world's best human "Jeopardy!" champions, is going to college.
IBM sees five tech-powered changes in next five years
Dec 17, 2013
Technology stalwart IBM on Tuesday predicted classrooms getting to know students and doctors using DNA to customize care are among five big changes on the horizon.
Recommended for you
Early brain development implicated in Restless Legs Syndrome
2 hours ago
In a study published online in Genome Research, researchers of the Helmholtz Zentrum München und the Technische Universität München have demonstrated that a common genetic variant associated with Restless Legs Syndrome (RLS) ...
New genetic analysis identifies ancestry, reduces false positives in pinpointing disease
Mar 18, 2014
(Medical Xpress)—Ancestral background has much to do with our likelihood of developing or staving off disease. But separating the associations between who we are and where we come from, and genetic variations ...
New research links body clocks to chronic lung diseases
Mar 17, 2014
(Medical Xpress)—The body clock's natural rhythm could be utilized to improve current therapies to delay the onset of chronic lung diseases.
Taking immune cells for a test drive
Mar 17, 2014
You're on a crowded subway car and someone nearby sneezes. Influenza viruses shed by your fellow rider are expelled in droplets of saliva that land on you and the person next to you. Two days later, you begin suffering from ...
Novel gene-finding approach yields a new gene linked to key heart attack risk factor
Mar 16, 2014
Scientists have discovered a previously unrecognized gene variation that makes humans have healthier blood lipid levels and reduced risk of heart attacks—a finding that opens the door to using this knowledge in testing ...
Cancer therapy may be too targeted
Mar 16, 2014
Researchers have identified two novel cancer genes that are associated with the development of a rare, highly aggressive, cancer of blood vessels. These genes may now act as markers for future treatments and explain why narrowly ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment